The promise and pitfalls of monoclonal antibody therapeutics

被引：24

作者：

Berkower, I

机构：

[1] Laboratory of Immunoregulation, Div. of Allergenic Prod. and P., Ctr. for Biologics, Food and Admin., Bethesda

来源：

CURRENT OPINION IN BIOTECHNOLOGY | 1996年 / 7卷 / 06期

关键词：

D O I：

10.1016/S0958-1669(96)80073-5

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Recent experience has helped io clarify the best ways to use monoclonal antibodies to solve clinical problems. For example, imaging based on tumor antigens, rather than tumor size, will permit early detection of cancer and accurate staging. Blocking receptor-ligand interactions may permit therapeutic intervention in cell growth or function but activity may depend on the choice of an antiligand or antireceptor strategy. Humanized antibodies will achieve greater intensity and duration of therapy, while allowing repeat administration in chronic diseases. (C) Current Biology Ltd ISSN 0958-1669..

引用

页码：622 / 628

页数：7

共 51 条

[11] IMMUNOSCINTIGRAPHY PERFORMED WITH IN-111 LABELED CYT-103 IN THE MANAGEMENT OF COLORECTAL-CANCER - COMPARISON WITH CT [J].

COLLIER, BD ;

ABDELNABI, H ;

DOERR, RJ ;

HARWOOD, SJ ;

OLSEN, J ;

KAPLAN, EH ;

WINZELBERG, GG ;

GROSSMAN, SJ ;

KRAG, DN ;

MITCHELL, EP .

RADIOLOGY, 1992, 185 (01) :179-186

[12]

Coons T, 1995, Radiol Technol, V67, P39

[13] RADIOLABELED ANTIBODY IMAGING IN THE MANAGEMENT OF COLORECTAL-CANCER - RESULTS OF A MULTICENTER CLINICAL-STUDY [J].

DOERR, RJ ;

ABDELNABI, H ;

KRAG, D ;

MITCHELL, E .

ANNALS OF SURGERY, 1991, 214 (02) :118-124

[14]

FEI DTW, 1994, J IMMUNOL METHODS, V171, P189

[15] Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein [J].

Fisher, CJ ;

Agosti, JM ;

Opal, SM ;

Lowry, SF ;

Balk, RA ;

Sadoff, JC ;

Abraham, E ;

Schein, RMH ;

Benjamin, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1697-1702

[16] SPECIFIC AND STABLE LABELING OF ANTIBODIES WITH TECHNETIUM-99M WITH A DIAMIDE DITHIOLATE CHELATING AGENT [J].

FRITZBERG, AR ;

ABRAMS, PG ;

BEAUMIER, PL ;

KASINA, S ;

MORGAN, AC ;

RAO, TN ;

RENO, JM ;

SANDERSON, JA ;

SRINIVASAN, A ;

WILBUR, DS ;

VANDERHEYDEN, JL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (11) :4025-4029

[17]

GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337

[18] A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS [J].

GREENMAN, RL ;

SCHEIN, RMH ;

MARTIN, MA ;

WENZEL, RP ;

MACINTYRE, NR ;

EMMANUEL, G ;

CHMEL, H ;

KOHLER, RB ;

MCCARTHY, M ;

PLOUFFE, J ;

RUSSELL, JA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08) :1097-1102

[19]

Greiner JW, 1996, ANTICANCER RES, V16, P2129

[20]

HENRICKSON M, 1995, TRANSPLANTATION, V60, P828

← 1 2 3 4 5 6 →